159 related articles for article (PubMed ID: 12476046)
1. Leukocyte adhesion deficiency II: therapy and genetic defect.
Wild MK; Lühn K; Marquardt T; Vestweber D
Cells Tissues Organs; 2002; 172(3):161-73. PubMed ID: 12476046
[TBL] [Abstract][Full Text] [Related]
2. Insights into leukocyte adhesion deficiency type 2 from a novel mutation in the GDP-fucose transporter gene.
Hidalgo A; Ma S; Peired AJ; Weiss LA; Cunningham-Rundles C; Frenette PS
Blood; 2003 Mar; 101(5):1705-12. PubMed ID: 12406889
[TBL] [Abstract][Full Text] [Related]
3. The gene defective in leukocyte adhesion deficiency II encodes a putative GDP-fucose transporter.
Lühn K; Wild MK; Eckhardt M; Gerardy-Schahn R; Vestweber D
Nat Genet; 2001 May; 28(1):69-72. PubMed ID: 11326279
[TBL] [Abstract][Full Text] [Related]
4. Leukocyte adhesion deficiency II-from A to almost Z.
Etzioni A; Tonetti M
Immunol Rev; 2000 Dec; 178():138-47. PubMed ID: 11213799
[TBL] [Abstract][Full Text] [Related]
5. Correction of leukocyte adhesion deficiency type II with oral fucose.
Marquardt T; Lühn K; Srikrishna G; Freeze HH; Harms E; Vestweber D
Blood; 1999 Dec; 94(12):3976-85. PubMed ID: 10590041
[TBL] [Abstract][Full Text] [Related]
6. Core fucosylation of N-linked glycans in leukocyte adhesion deficiency/congenital disorder of glycosylation IIc fibroblasts.
Sturla L; Fruscione F; Noda K; Miyoshi E; Taniguchi N; Contini P; Tonetti M
Glycobiology; 2005 Oct; 15(10):924-34. PubMed ID: 15917429
[TBL] [Abstract][Full Text] [Related]
7. Leukocyte Adhesion Deficiency Type II is a generalized defect of de novo GDP-fucose biosynthesis. Endothelial cell fucosylation is not required for neutrophil rolling on human nonlymphoid endothelium.
Karsan A; Cornejo CJ; Winn RK; Schwartz BR; Way W; Lannir N; Gershoni-Baruch R; Etzioni A; Ochs HD; Harlan JM
J Clin Invest; 1998 Jun; 101(11):2438-45. PubMed ID: 9616215
[TBL] [Abstract][Full Text] [Related]
8. Impairment of the Golgi GDP-L-fucose transport and unresponsiveness to fucose replacement therapy in LAD II patients.
Sturla L; Puglielli L; Tonetti M; Berninsone P; Hirschberg CB; De Flora A; Etzioni A
Pediatr Res; 2001 Apr; 49(4):537-42. PubMed ID: 11264438
[TBL] [Abstract][Full Text] [Related]
9. Leukocyte adhesion deficiency II patients with a dual defect of the GDP-fucose transporter.
Helmus Y; Denecke J; Yakubenia S; Robinson P; Lühn K; Watson DL; McGrogan PJ; Vestweber D; Marquardt T; Wild MK
Blood; 2006 May; 107(10):3959-66. PubMed ID: 16455955
[TBL] [Abstract][Full Text] [Related]
10. Hematologically important mutations: leukocyte adhesion deficiency (first update).
van de Vijver E; Maddalena A; Sanal Ö; Holland SM; Uzel G; Madkaikar M; de Boer M; van Leeuwen K; Köker MY; Parvaneh N; Fischer A; Law SK; Klein N; Tezcan FI; Unal E; Patiroglu T; Belohradsky BH; Schwartz K; Somech R; Kuijpers TW; Roos D
Blood Cells Mol Dis; 2012 Jan; 48(1):53-61. PubMed ID: 22134107
[TBL] [Abstract][Full Text] [Related]
11. Differential terminal fucosylation of N-linked glycans versus protein O-fucosylation in leukocyte adhesion deficiency type II (CDG IIc).
Sturla L; Rampal R; Haltiwanger RS; Fruscione F; Etzioni A; Tonetti M
J Biol Chem; 2003 Jul; 278(29):26727-33. PubMed ID: 12738772
[TBL] [Abstract][Full Text] [Related]
12. Notch deficiency implicated in the pathogenesis of congenital disorder of glycosylation IIc.
Ishikawa HO; Higashi S; Ayukawa T; Sasamura T; Kitagawa M; Harigaya K; Aoki K; Ishida N; Sanai Y; Matsuno K
Proc Natl Acad Sci U S A; 2005 Dec; 102(51):18532-7. PubMed ID: 16344471
[TBL] [Abstract][Full Text] [Related]
13. A novel mutation in leukocyte adhesion deficiency type II/CDGIIc.
Cagdas D; Yilmaz M; Kandemir N; Tezcan I; Etzioni A; Sanal Ö
J Clin Immunol; 2014 Nov; 34(8):1009-14. PubMed ID: 25239688
[TBL] [Abstract][Full Text] [Related]
14. Hematologically important mutations: leukocyte adhesion deficiency.
Roos D; Law SK
Blood Cells Mol Dis; 2001; 27(6):1000-4. PubMed ID: 11831866
[TBL] [Abstract][Full Text] [Related]
15. Golgi nucleotide sugar transport and leukocyte adhesion deficiency II.
Hirschberg CB
J Clin Invest; 2001 Jul; 108(1):3-6. PubMed ID: 11435449
[No Abstract] [Full Text] [Related]
16. Identification and molecular cloning of a functional GDP-fucose transporter in Drosophila melanogaster.
Lühn K; Laskowska A; Pielage J; Klämbt C; Ipe U; Vestweber D; Wild MK
Exp Cell Res; 2004 Dec; 301(2):242-50. PubMed ID: 15530860
[TBL] [Abstract][Full Text] [Related]
17. Leukocyte adhesion deficiency type II.
Becker DJ; Lowe JB
Biochim Biophys Acta; 1999 Oct; 1455(2-3):193-204. PubMed ID: 10571012
[TBL] [Abstract][Full Text] [Related]
18. Leukocyte adhesion deficiency II syndrome, a generalized defect in fucose metabolism.
Marquardt T; Brune T; Lühn K; Zimmer KP; Körner C; Fabritz L; van der Werft N; Vormoor J; Freeze HH; Louwen F; Biermann B; Harms E; von Figura K; Vestweber D; Koch HG
J Pediatr; 1999 Jun; 134(6):681-8. PubMed ID: 10356134
[TBL] [Abstract][Full Text] [Related]
19. Incorporation of fucose into glycans independent of the GDP-fucose transporter SLC35C1 preferentially utilizes salvaged over de novo GDP-fucose.
Skurska E; Szulc B; Maszczak-Seneczko D; Wiktor M; Wiertelak W; Makowiecka A; Olczak M
J Biol Chem; 2022 Aug; 298(8):102206. PubMed ID: 35772493
[TBL] [Abstract][Full Text] [Related]
20. Discontinuation of fucose therapy in LADII causes rapid loss of selectin ligands and rise of leukocyte counts.
Lühn K; Marquardt T; Harms E; Vestweber D
Blood; 2001 Jan; 97(1):330-2. PubMed ID: 11133780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
